Infographic: Engineering Microbiomes with CRISPR

Researchers are using CRISPR for precise genetic manipulation of human-associated microbes as a promising avenue for improving human health.

Written byMariella Bodemeier Loayza Careaga, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The microbes that make up an organism’s microbiome have a range of effects on its health. Scientists use CRISPR systems to genetically manipulate specific bacterial species, for instance those found in the mouse gut microbiome, to find new ways to promote health and treat disease.

TK
© nanoclustering.com

(1) Scientists select a specific microbe, such as a bacterial species, for CRISPR-mediated genetic manipulation.

(2) Researchers deliver CRISPR system components using different methods, including conjugation, transformation by heat shock or electroporation, and transduction by bacteriophages.

(3) Scientists directly provide the sequence encoding all CRISPR components, a Cas protein and a guide RNA, into the target microbe.

(4) Alternatively, scientists co-opt the bacteria’s endogenous CRISPR machinery and supply only the guide RNA.

(5) Scientists edit the microbe’s DNA or cause irreparable breaks that lead to DNA degradation.

TK
© nanoclustering.com

(6) In bacteria, scientists modify either the plasmid or chromosomal DNA of the microbe. In complex microbial communities such as the gut microbiome, CRISPR-engineered bacteria have multiple applications.

(7) Engineered probiotic bacteria produce modulatory molecules to fight diseases and restore the intestinal flora.

(8) As an antimicrobial, CRISPR self-targets the DNA of a pathogenic bacterial strain.

(9) By CRISPR editing commensal gut bacteria, scientists modulate the effects of these microbes on the microbiome and influence disease related processes such as inflammation.

Read the full story.

Related Topics

Meet the Author

  • Black and white portrait by Mariella Bodemeier Loayza Careaga, PhD

    Mariella joined The Scientist in 2023. Before that, she was a postdoctoral researcher at the Uniformed Services University of the Health Sciences studying sex differences on the effects of chronic stress and traumatic brain injury. Mariella holds a master’s and a PhD in neuroscience from the Universidade Federal de Sao Paulo, Brazil, and a certificate in Science Communication from the University of California, San Diego.

    View Full Profile

Published In

Spring 2024 cover
Spring 2024

Turning on the Bat Signal

Research into bat immune systems may help keep humans safe from viral attacks.

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies